GSK3B and early-onset autosomal dominant Alzheimer disease: Our finding agrees with previous studies that down-regulation of hsa-miR-124-3p was observed in an Alzheimer's Disease (AD) model, contributing to neuroprotection via the regulation of PI3K/Akt/GSK3β pathway in neurological diseases to reduce the release of pro-inflammatory cytokines 47.